BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld Asia
Home
» In the clinic for April 13-19, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for April 13-19, 2021
April 20, 2021
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Adagio, Adlai Nortye, Aegis Life, Anji, Ardelyx, Atriva, Bergenbio, Covis, Gannex, H. Lundbeck, Implicit, Kinarus, Kintor, Kyowa Kirin, Mei, Merck, Nervgen, Novavax, Otsuka, Pharmabcine, Prexa Sante, Quantum Leap Healthcare, Recce, Ridgeback, Rigel, Romark Laboratories, Takeda, Todos Medical, Transcenta, Urovant Sciences.
BioWorld Asia
Briefs
In the clinic